EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy

Yajuan Yan, Ting Duan, Xiaonan Xue, Xiaojuan Yang, Miao Liu, Bin Ma, Xiangguo Duan, Chunxia Su

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s492734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Yajuan Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Ningxia Medical University, Yinchuan, People's Republic of China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cancer Vaccines, Immune Checkpoint Inhibitors, Receptors, Virus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCancer VaccinesImmune Checkpoint InhibitorsReceptors, VirusAnimalsLiposomesMiceHumansDendritic CellsTumor MicroenvironmentCell Line, TumorToll-Like Receptor 4Mice, Inbred C57BLFemaleCD8-Positive T-LymphocytesMice, Inbred BALB CDrugs, Chinese HerbalNanovaccines

Stichwörter der Autor:innen

CD155Lycium barbarum polysaccharidesnanovaccine codeliverynanovaccinestumor immunotherapy

Substanzen

LiposomesCancer VaccinesImmune Checkpoint InhibitorsToll-Like Receptor 4Receptors, VirusDrugs, Chinese HerbalNanovaccines

Autor:innen und Institutionen

  • School of Basic Medicine, Ningxia Medical University, Yinchuan, People's Republic of China.
  • School of Inspection, Ningxia Medical University, Yinchuan, People's Republic of China.
  • Department of Surgery, The First People's Hospital of Yinchuan, Yinchuan, Ningxia, People's Republic of China.
  • The Second School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, People's Republic of China.

Zitieren

APA

Yan, Y., Duan, T., Xue, X., Yang, X., Liu, M., Ma, B., Duan, X., & Su, C. (2025). LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s492734

Vancouver

Yan Y, Duan T, Xue X, Yang X, Liu M, Ma B, et al. LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s492734

BibTeX
@article{Yan2025,
  author = {Yan, Yajuan and Duan, Ting and Xue, Xiaonan and Yang, Xiaojuan and Liu, Miao and Ma, Bin and Duan, Xiangguo and Su, Chunxia},
  title = {LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s492734}
}
Kostenlos starten →